Koide, Shohei

The fibronectin type III domain as a scaffold for novel binding proteins

Koide, A., Bailey, C. W., Huang, X., & Koide, S. (1998) · Journal of Molecular Biology

Protein Structure and DynamicsBiochemical and Structural Characterization

Cited by 585

Inhibition of RAS function through targeting an allosteric regulatory site

Spencer-Smith, R., Koide, A., Zhou, Y., Eguchi, R. R., Sha, F., Gajwani, P., Santana, D., Gupta, A., Jacobs, M., Herrero-Garcia, E., et al. (2017) · Nature Chemical Biology

Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

Cited by 283

SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling

Fedele, C., Li, S., Teng, K. W., Foster, C. J. R., Peng, D., Ran, H., Mita, P., Geer, M. J., Hattori, T., Koide, A., et al. (2021) · Journal of Experimental Medicine

Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling

Cited by 265

Teaching an Old Scaffold New Tricks: Monobodies Constructed Using Alternative Surfaces of the FN3 Scaffold

Koide, A., Wojcik, J., Gilbreth, R. N., Hoey, R. J., & Koide, S. (2012) · Journal of Molecular Biology

Monoclonal and Polyclonal Antibodies ResearchBiochemical and Structural Characterization

Cited by 227

Target-Binding Proteins Based on the 10th Human Fibronectin Type III Domain (10Fn3)

Koide, S., Koide, A., & Lipovšek, D. (2012) · Methods in Enzymology

Monoclonal and Polyclonal Antibodies ResearchBiochemical and Structural Characterization

Cited by 84

Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy

Hattori, T., Maso, L., Araki, K. Y., Koide, A., Hayman, J., Akkapeddi, P., Bang, I., Neel, B. G., & Koide, S. (2023) · Cancer Discovery

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 72